1. Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes
   Yangying Zhou et al, 2018, Neoplasia CrossRef
2. Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer
   Rachel K. Toth et al, 2021, Molecular Cancer Therapeutics CrossRef
3. PIM kinases: From survival factors to regulators of cell motility
   Niina M. Santio et al, 2017, The International Journal of Biochemistry & Cell Biology CrossRef
4. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
   Ann Lin et al, 2019, Science Translational Medicine CrossRef
5. Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics
   Lin Lai et al, 2022, Cancer Control CrossRef
6. Duplicate genes as sources for rapid adaptive evolution of sperm under environmental pollution in tree sparrow
   Shengnan Wang et al, 2023, Molecular Ecology CrossRef
7. PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer
   Pedro Torres-Ayuso et al, 2024, Cell Chemical Biology CrossRef
8. Targeting Super-Enhancer–Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor
   Jiajun Zhang et al, 2020, Clinical Cancer Research CrossRef